Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may enhance the drug's ability to manage blood levels, potentially offering improved outcomes for individuals with insulin resistance. Further study is underway to fully understand the long-